The global Sickle Cell Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report aims to provide a comprehensive presentation of the global market for Sickle Cell Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sickle Cell Treatment. This report contains market size and forecasts of Sickle Cell Treatment in global, including the following market information:
- Global Sickle Cell Treatment Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Blood Transfusion Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Sickle Cell Treatment include Novartis AG, Global Blood Therapeutics Inc., EMI Holding, Inc., Addmedica Inc., Medunik USA.Inc., Bristol Myers Squibb Co., Baxter Inc., Bluebird Biotechnology and Pfizer Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
WE surveyed the Sickle Cell Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sickle Cell Treatment Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Sickle Cell Treatment Market Segment Percentages, by Type, 2022 (%)
- Blood Transfusion
- Bone Marrow Transplant
- Pharmacotherapy
Global Sickle Cell Treatment Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Sickle Cell Treatment Market Segment Percentages, by Application, 2022 (%)
Global Sickle Cell Treatment Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Sickle Cell Treatment Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Sickle Cell Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Sickle Cell Treatment revenues share in global market, 2022 (%)
key players include:
- Novartis AG
- Global Blood Therapeutics Inc.
- EMI Holding, Inc.
- Addmedica Inc.
- Medunik USA.Inc.
- Bristol Myers Squibb Co.
- Baxter Inc.
- Bluebird Biotechnology
- Pfizer Inc.
- Eli-Lilly and Co.
- Glycomimetics Inc.
- F.Hoffmann-La Roche
- CRISPR Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Sickle Cell Treatment, market overview.
Chapter 2: Global Sickle Cell Treatment market size in revenue.
Chapter 3: Detailed analysis of Sickle Cell Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments
by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments
by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sickle Cell Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Sickle Cell Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sickle Cell Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Sickle Cell Treatment Overall Market Size
2.1 Global Sickle Cell Treatment Market Size: 2022 VS 2032
2.2 Global Sickle Cell Treatment Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Sickle Cell Treatment Players in Global Market
3.2 Top Global Sickle Cell Treatment Companies Ranked by Revenue
3.3 Global Sickle Cell Treatment Revenue by Companies
3.4 Top 3 and Top 5 Sickle Cell Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Sickle Cell Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Sickle Cell Treatment Players in Global Market
3.6.1 List of Global Tier 1 Sickle Cell Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Sickle Cell Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Sickle Cell Treatment Market Size Markets, 2022 & 2032
4.1.2 Blood Transfusion
4.1.3 Bone Marrow Transplant
4.1.4 Pharmacotherapy
4.2 By Type - Global Sickle Cell Treatment Revenue & Forecasts
4.2.1 By Type - Global Sickle Cell Treatment Revenue, 2018-2023
4.2.2 By Type - Global Sickle Cell Treatment Revenue, 2024-2032
4.2.3 By Type - Global Sickle Cell Treatment Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Sickle Cell Treatment Market Size, 2022 & 2032
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Sickle Cell Treatment Revenue & Forecasts
5.2.1 By Application - Global Sickle Cell Treatment Revenue, 2018-2023
5.2.2 By Application - Global Sickle Cell Treatment Revenue, 2024-2032
5.2.3 By Application - Global Sickle Cell Treatment Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Sickle Cell Treatment Market Size, 2022 & 2032
6.2 By Region - Global Sickle Cell Treatment Revenue & Forecasts
6.2.1 By Region - Global Sickle Cell Treatment Revenue, 2018-2023
6.2.2 By Region - Global Sickle Cell Treatment Revenue, 2024-2032
6.2.3 By Region - Global Sickle Cell Treatment Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Sickle Cell Treatment Revenue, 2018-2032
6.3.2 US Sickle Cell Treatment Market Size, 2018-2032
6.3.3 Canada Sickle Cell Treatment Market Size, 2018-2032
6.3.4 Mexico Sickle Cell Treatment Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Sickle Cell Treatment Revenue, 2018-2032
6.4.2 Germany Sickle Cell Treatment Market Size, 2018-2032
6.4.3 France Sickle Cell Treatment Market Size, 2018-2032
6.4.4 U.K. Sickle Cell Treatment Market Size, 2018-2032
6.4.5 Italy Sickle Cell Treatment Market Size, 2018-2032
6.4.6 Russia Sickle Cell Treatment Market Size, 2018-2032
6.4.7 Nordic Countries Sickle Cell Treatment Market Size, 2018-2032
6.4.8 Benelux Sickle Cell Treatment Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Sickle Cell Treatment Revenue, 2018-2032
6.5.2 China Sickle Cell Treatment Market Size, 2018-2032
6.5.3 Japan Sickle Cell Treatment Market Size, 2018-2032
6.5.4 South Korea Sickle Cell Treatment Market Size, 2018-2032
6.5.5 Southeast Asia Sickle Cell Treatment Market Size, 2018-2032
6.5.6 India Sickle Cell Treatment Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Sickle Cell Treatment Revenue, 2018-2032
6.6.2 Brazil Sickle Cell Treatment Market Size, 2018-2032
6.6.3 Argentina Sickle Cell Treatment Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Sickle Cell Treatment Revenue, 2018-2032
6.7.2 Turkey Sickle Cell Treatment Market Size, 2018-2032
6.7.3 Israel Sickle Cell Treatment Market Size, 2018-2032
6.7.4 Saudi Arabia Sickle Cell Treatment Market Size, 2018-2032
6.7.5 UAE Sickle Cell Treatment Market Size, 2018-2032
7 Sickle Cell Treatment Companies Profiles
7.1 Novartis AG
7.1.1 Novartis AG Company Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Sickle Cell Treatment Major Product Offerings
7.1.4 Novartis AG Sickle Cell Treatment Revenue in Global Market (2018-2023)
7.1.5 Novartis AG Key News & Latest Developments
7.2 Global Blood Therapeutics Inc.
7.2.1 Global Blood Therapeutics Inc. Company Summary
7.2.2 Global Blood Therapeutics Inc. Business Overview
7.2.3 Global Blood Therapeutics Inc. Sickle Cell Treatment Major Product Offerings
7.2.4 Global Blood Therapeutics Inc. Sickle Cell Treatment Revenue in Global Market (2018-2023)
7.2.5 Global Blood Therapeutics Inc. Key News & Latest Developments
7.3 EMI Holding, Inc.
7.3.1 EMI Holding, Inc. Company Summary
7.3.2 EMI Holding, Inc. Business Overview
7.3.3 EMI Holding, Inc. Sickle Cell Treatment Major Product Offerings
7.3.4 EMI Holding, Inc. Sickle Cell Treatment Revenue in Global Market (2018-2023)
7.3.5 EMI Holding, Inc. Key News & Latest Developments
7.4 Addmedica Inc.
7.4.1 Addmedica Inc. Company Summary
7.4.2 Addmedica Inc. Business Overview
7.4.3 Addmedica Inc. Sickle Cell Treatment Major Product Offerings
7.4.4 Addmedica Inc. Sickle Cell Treatment Revenue in Global Market (2018-2023)
7.4.5 Addmedica Inc. Key News & Latest Developments
7.5 Medunik USA.Inc.
7.5.1 Medunik USA.Inc. Company Summary
7.5.2 Medunik USA.Inc. Business Overview
7.5.3 Medunik USA.Inc. Sickle Cell Treatment Major Product Offerings
7.5.4 Medunik USA.Inc. Sickle Cell Treatment Revenue in Global Market (2018-2023)
7.5.5 Medunik USA.Inc. Key News & Latest Developments
7.6 Bristol Myers Squibb Co.
7.6.1 Bristol Myers Squibb Co. Company Summary
7.6.2 Bristol Myers Squibb Co. Business Overview
7.6.3 Bristol Myers Squibb Co. Sickle Cell Treatment Major Product Offerings
7.6.4 Bristol Myers Squibb Co. Sickle Cell Treatment Revenue in Global Market (2018-2023)
7.6.5 Bristol Myers Squibb Co. Key News & Latest Developments
7.7 Baxter Inc.
7.7.1 Baxter Inc. Company Summary
7.7.2 Baxter Inc. Business Overview
7.7.3 Baxter Inc. Sickle Cell Treatment Major Product Offerings
7.7.4 Baxter Inc. Sickle Cell Treatment Revenue in Global Market (2018-2023)
7.7.5 Baxter Inc. Key News & Latest Developments
7.8 Bluebird Biotechnology
7.8.1 Bluebird Biotechnology Company Summary
7.8.2 Bluebird Biotechnology Business Overview
7.8.3 Bluebird Biotechnology Sickle Cell Treatment Major Product Offerings
7.8.4 Bluebird Biotechnology Sickle Cell Treatment Revenue in Global Market (2018-2023)
7.8.5 Bluebird Biotechnology Key News & Latest Developments
7.9 Pfizer Inc.
7.9.1 Pfizer Inc. Company Summary
7.9.2 Pfizer Inc. Business Overview
7.9.3 Pfizer Inc. Sickle Cell Treatment Major Product Offerings
7.9.4 Pfizer Inc. Sickle Cell Treatment Revenue in Global Market (2018-2023)
7.9.5 Pfizer Inc. Key News & Latest Developments
7.10 Eli-Lilly and Co.
7.10.1 Eli-Lilly and Co. Company Summary
7.10.2 Eli-Lilly and Co. Business Overview
7.10.3 Eli-Lilly and Co. Sickle Cell Treatment Major Product Offerings
7.10.4 Eli-Lilly and Co. Sickle Cell Treatment Revenue in Global Market (2018-2023)
7.10.5 Eli-Lilly and Co. Key News & Latest Developments
7.11 Glycomimetics Inc.
7.11.1 Glycomimetics Inc. Company Summary
7.11.2 Glycomimetics Inc. Business Overview
7.11.3 Glycomimetics Inc. Sickle Cell Treatment Major Product Offerings
7.11.4 Glycomimetics Inc. Sickle Cell Treatment Revenue in Global Market (2018-2023)
7.11.5 Glycomimetics Inc. Key News & Latest Developments
7.12 F.Hoffmann-La Roche
7.12.1 F.Hoffmann-La Roche Company Summary
7.12.2 F.Hoffmann-La Roche Business Overview
7.12.3 F.Hoffmann-La Roche Sickle Cell Treatment Major Product Offerings
7.12.4 F.Hoffmann-La Roche Sickle Cell Treatment Revenue in Global Market (2018-2023)
7.12.5 F.Hoffmann-La Roche Key News & Latest Developments
7.13 CRISPR Therapeutics
7.13.1 CRISPR Therapeutics Company Summary
7.13.2 CRISPR Therapeutics Business Overview
7.13.3 CRISPR Therapeutics Sickle Cell Treatment Major Product Offerings
7.13.4 CRISPR Therapeutics Sickle Cell Treatment Revenue in Global Market (2018-2023)
7.13.5 CRISPR Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Sickle Cell Treatment Market Opportunities & Trends in Global Market
Table 2. Sickle Cell Treatment Market Drivers in Global Market
Table 3. Sickle Cell Treatment Market Restraints in Global Market
Table 4. Key Players of Sickle Cell Treatment in Global Market
Table 5. Top Sickle Cell Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Sickle Cell Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Sickle Cell Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Sickle Cell Treatment Product Type
Table 9. List of Global Tier 1 Sickle Cell Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sickle Cell Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Sickle Cell Treatment Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Sickle Cell Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Sickle Cell Treatment Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Sickle Cell Treatment Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Sickle Cell Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Sickle Cell Treatment Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Sickle Cell Treatment Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Sickle Cell Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Sickle Cell Treatment Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Sickle Cell Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Sickle Cell Treatment Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Sickle Cell Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Sickle Cell Treatment Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Sickle Cell Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Sickle Cell Treatment Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Sickle Cell Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Sickle Cell Treatment Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Sickle Cell Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Sickle Cell Treatment Revenue, (US$, Mn), 2024-2032
Table 30. Novartis AG Company Summary
Table 31. Novartis AG Sickle Cell Treatment Product Offerings
Table 32. Novartis AG Sickle Cell Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis AG Key News & Latest Developments
Table 34. Global Blood Therapeutics Inc. Company Summary
Table 35. Global Blood Therapeutics Inc. Sickle Cell Treatment Product Offerings
Table 36. Global Blood Therapeutics Inc. Sickle Cell Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Global Blood Therapeutics Inc. Key News & Latest Developments
Table 38. EMI Holding, Inc. Company Summary
Table 39. EMI Holding, Inc. Sickle Cell Treatment Product Offerings
Table 40. EMI Holding, Inc. Sickle Cell Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. EMI Holding, Inc. Key News & Latest Developments
Table 42. Addmedica Inc. Company Summary
Table 43. Addmedica Inc. Sickle Cell Treatment Product Offerings
Table 44. Addmedica Inc. Sickle Cell Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Addmedica Inc. Key News & Latest Developments
Table 46. Medunik USA.Inc. Company Summary
Table 47. Medunik USA.Inc. Sickle Cell Treatment Product Offerings
Table 48. Medunik USA.Inc. Sickle Cell Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Medunik USA.Inc. Key News & Latest Developments
Table 50. Bristol Myers Squibb Co. Company Summary
Table 51. Bristol Myers Squibb Co. Sickle Cell Treatment Product Offerings
Table 52. Bristol Myers Squibb Co. Sickle Cell Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Bristol Myers Squibb Co. Key News & Latest Developments
Table 54. Baxter Inc. Company Summary
Table 55. Baxter Inc. Sickle Cell Treatment Product Offerings
Table 56. Baxter Inc. Sickle Cell Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Baxter Inc. Key News & Latest Developments
Table 58. Bluebird Biotechnology Company Summary
Table 59. Bluebird Biotechnology Sickle Cell Treatment Product Offerings
Table 60. Bluebird Biotechnology Sickle Cell Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. Bluebird Biotechnology Key News & Latest Developments
Table 62. Pfizer Inc. Company Summary
Table 63. Pfizer Inc. Sickle Cell Treatment Product Offerings
Table 64. Pfizer Inc. Sickle Cell Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. Pfizer Inc. Key News & Latest Developments
Table 66. Eli-Lilly and Co. Company Summary
Table 67. Eli-Lilly and Co. Sickle Cell Treatment Product Offerings
Table 68. Eli-Lilly and Co. Sickle Cell Treatment Revenue (US$, Mn) & (2018-2023)
Table 69. Eli-Lilly and Co. Key News & Latest Developments
Table 70. Glycomimetics Inc. Company Summary
Table 71. Glycomimetics Inc. Sickle Cell Treatment Product Offerings
Table 72. Glycomimetics Inc. Sickle Cell Treatment Revenue (US$, Mn) & (2018-2023)
Table 73. Glycomimetics Inc. Key News & Latest Developments
Table 74. F.Hoffmann-La Roche Company Summary
Table 75. F.Hoffmann-La Roche Sickle Cell Treatment Product Offerings
Table 76. F.Hoffmann-La Roche Sickle Cell Treatment Revenue (US$, Mn) & (2018-2023)
Table 77. F.Hoffmann-La Roche Key News & Latest Developments
Table 78. CRISPR Therapeutics Company Summary
Table 79. CRISPR Therapeutics Sickle Cell Treatment Product Offerings
Table 80. CRISPR Therapeutics Sickle Cell Treatment Revenue (US$, Mn) & (2018-2023)
Table 81. CRISPR Therapeutics Key News & Latest Developments
List of Figures
Figure 1. Sickle Cell Treatment Segment by Type in 2022
Figure 2. Sickle Cell Treatment Segment by Application in 2022
Figure 3. Global Sickle Cell Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Sickle Cell Treatment Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Sickle Cell Treatment Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Sickle Cell Treatment Revenue in 2022
Figure 8. By Type - Global Sickle Cell Treatment Revenue Market Share, 2018-2032
Figure 9. By Application - Global Sickle Cell Treatment Revenue Market Share, 2018-2032
Figure 10. By Type - Global Sickle Cell Treatment Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Sickle Cell Treatment Revenue Market Share, 2018-2032
Figure 12. By Application - Global Sickle Cell Treatment Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Sickle Cell Treatment Revenue Market Share, 2018-2032
Figure 14. By Region - Global Sickle Cell Treatment Revenue Market Share, 2018-2032
Figure 15. By Country - North America Sickle Cell Treatment Revenue Market Share, 2018-2032
Figure 16. US Sickle Cell Treatment Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Sickle Cell Treatment Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Sickle Cell Treatment Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Sickle Cell Treatment Revenue Market Share, 2018-2032
Figure 20. Germany Sickle Cell Treatment Revenue, (US$, Mn), 2018-2032
Figure 21. France Sickle Cell Treatment Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Sickle Cell Treatment Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Sickle Cell Treatment Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Sickle Cell Treatment Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Sickle Cell Treatment Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Sickle Cell Treatment Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Sickle Cell Treatment Revenue Market Share, 2018-2032
Figure 28. China Sickle Cell Treatment Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Sickle Cell Treatment Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Sickle Cell Treatment Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Sickle Cell Treatment Revenue, (US$, Mn), 2018-2032
Figure 32. India Sickle Cell Treatment Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Sickle Cell Treatment Revenue Market Share, 2018-2032
Figure 34. Brazil Sickle Cell Treatment Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Sickle Cell Treatment Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Sickle Cell Treatment Revenue Market Share, 2018-2032
Figure 37. Turkey Sickle Cell Treatment Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Sickle Cell Treatment Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Sickle Cell Treatment Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Sickle Cell Treatment Revenue, (US$, Mn), 2018-2032
Figure 41. Novartis AG Sickle Cell Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Global Blood Therapeutics Inc. Sickle Cell Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. EMI Holding, Inc. Sickle Cell Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Addmedica Inc. Sickle Cell Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Medunik USA.Inc. Sickle Cell Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Bristol Myers Squibb Co. Sickle Cell Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Baxter Inc. Sickle Cell Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Bluebird Biotechnology Sickle Cell Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Pfizer Inc. Sickle Cell Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Eli-Lilly and Co. Sickle Cell Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Glycomimetics Inc. Sickle Cell Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. F.Hoffmann-La Roche Sickle Cell Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. CRISPR Therapeutics Sickle Cell Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
